We found that miR-206, the most highly expressed miRNA in type 2–high asthma relative to type 2–low asthma, targets the CD39–extracelluar ATP axis to regulate IL-25 and TSLP expression in cultured bronchial epithelial cells. The gene discussed is TSLP; the disease is asthma.